Iktos Announces Collaboration with Merck KGaA, Darmstadt, Germany, for Use of Iktos AI Technology across Three Drug Discovery Projects


PARIS–(BUSINESS WIRE)–Iktos, a company specialized in Artificial Intelligence for new drug design, today announced a collaboration agreement with Merck KGaA, Darmstadt, Germany, a leading science and technology company, where Iktos generative modelling artificial intelligence (AI) technology will be used to facilitate the rapid and cost-effective discovery and design of promising new compounds for Merck KGaA, Darmstadt, Germany. Iktos’ AI technology, based on deep generative models, helps bri http://www.businesswire.com/news/home/20190314005524/en/Iktos-Announces-Collaboration-Merck-KGaA-Darmstadt-Germany/?feedref=JjAwJuNHiystnCoBq_hl-WBlLQO14j4QZPTyX5CYOnwC4VjN53jumZRlnzhBoBxGrCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3ltkRSnqzf6ourQGu_UA28CzZCGORvG0LE20YOvo49uqw==